For over two decades, Ruth Shaber worked as an OBGYN and medical leader, focused on improving women's healthcare through evidence and systems change.

A significant personal transition brought Ruth substantial wealth through Medivation stock, a biopharmaceutical company. Faced with this new financial responsibility, Ruth made a choice: rather than paying large capital gains taxes on her shares, she would use these resources to create a philanthropic foundation, drawing on her medical background to bring evidence-based rigor to philanthropy.

A significant personal transition brought Ruth substantial wealth through Medivation stock, a biopharmaceutical company. Faced with this new financial responsibility, Ruth made a choice: rather than paying large capital gains taxes on her shares, she would use these resources to create a philanthropic foundation, drawing on her medical background to bring evidence-based rigor to philanthropy.

A significant personal transition brought Ruth substantial wealth through Medivation stock, a biopharmaceutical company. Faced with this new financial responsibility, Ruth made a choice: rather than paying large capital gains taxes on her shares, she would use these resources to create a philanthropic foundation, drawing on her medical background to bring evidence-based rigor to philanthropy.

A significant personal transition brought Ruth substantial wealth through Medivation stock, a biopharmaceutical company. Faced with this new financial responsibility, Ruth made a choice: rather than paying large capital gains taxes on her shares, she would use these resources to create a philanthropic foundation, drawing on her medical background to bring evidence-based rigor to philanthropy.